Rachel Nosheny, PhD

Slotkin J, Kaat AJ, Young SR, Dworak EM, Novack MA, Shono Y, Adam H, Nowinski CJ, Pila S, Hosseinian Z, Varela Diaz M, Almonte-Correa A, Alperin K, Camacho MR, Landavazo B, Nosheny RL, Weiner MW, Gershon RC. Mobile Toolbox sequences task: development and validation of a remote, smartphone-based working memory test. Front Psychol. 2024; 15:1497816.

Kang JM, Manjavong M, Jin C, Diaz A, Ashford MT, Eichenbaum J, Thorp E, Wragg E, Zavitz KH, Cormack F, Aaronson A, Mackin RS, Tank R, Landavazo B, Cavallone E, Truran D, Farias ST, Weiner MW, Nosheny RL. Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry. Alzheimers Res Ther. 2025 Jan 07; 17(1):10.

Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR, Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP, Alzheimer's Disease Neuroimaging Initiative. Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials. Alzheimers Dement. 2025 Jan; 21(1):e14321.

Bleakley A, Maloney EK, Hennessy M, Hull S, Harkins K, Largent E, Ashford M, Kwang W, Byrd DR, Nosheny R, Karlawish J, Langbaum JB. Theory-Based Message Design for Recruitment of Underrepresented Racial/Ethnic Groups Into Alzheimer's-Focused Research Registries. Health Educ Behav. 2024 Nov 19; 10901981241296124.

Nosheny RL, Miller M, Conti C, Flenniken D, Ashford M, Diaz A, Fockler J, Truran D, Kwang W, Kanoria S, Veitch D, Green RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. The ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials. Alzheimers Dement. 2024 Dec; 20(12):9004-9013.

Manjavong M, Diaz A, Ashford MT, Aaronson A, Miller MJ, Kang JM, Mackin S, Tank R, Weiner M, Nosheny R, Alzheimer's Disease Neuroimaging Initiative. A short version of the Everyday Cognition scale can predict clinical progression and cognitive decline. Alzheimers Dement. 2024 Dec; 20(12):8651-8660.

Rivera Mindt M, Arentoft A, Calcetas AT, Guzman VA, Amaza H, Ajayi A, Ashford MT, Ayo O, Barnes LL, Camuy A, Conti C, Diaz A, Easter B, Gonzalez DJ, Dotson YG, Hoang I, Germano KK, Maestre GE, Magaña F, Meyer OL, Miller MJ, Nosheny R, Park VMT, Parkins S, Thomas LR, Strong J, Talavera S, Verney SP, Weisensel T, Weiner MW, Okonkwo OC, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's Disease Neuroimaging Initiative-4 (ADNI-4) Engagement Core: A culturally informed, community-engaged research (CI-CER) model to advance brain health equity. Alzheimers Dement. 2024 Dec; 20(12):8279-8293.

Guan DX, Mudalige D, Munro CE, Nosheny R, Smith EE, Ismail Z. The effect of study partner characteristics on the reporting of neuropsychiatric symptoms across the neurocognitive spectrum. Int Psychogeriatr. 2024 08; 36(8):675-688.

Rentz DM, Slotkin J, Kaat AJ, Young SR, Dworak EM, Shono Y, Adam H, Nowinski CJ, Pila S, Novack MA, Hosseinian Z, Amagai S, Diaz MV, Almonte-Correa A, Alperin K, Camacho MR, Landavazo B, Nosheny RL, Weiner MW, Gershon RC. Validity and reliability of the Mobile Toolbox Faces and Names memory test. J Neuropsychol. 2024 Sep 17.

Skirrow C, Meepegama U, Weston J, Miller MJ, Nosheny RL, Albala B, Weiner MW, Fristed E, Alzheimer's Disease Neuroimaging Initiative. Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech-based testing. Alzheimers Dement. 2024 Oct; 20(10):7248-7262.

Miller MJ, Diaz A, Conti C, Albala B, Flenniken D, Fockler J, Kwang W, Sacrey DT, Ashford MT, Skirrow C, Weston J, Fristed E, Farias ST, Korecka M, Wan Y, Aisen PS, Beckett L, Harvey D, Lee EB, Petersen RC, Shaw LM, Okonkwo OC, Mindt MR, Weiner MW, Nosheny RL, Alzheimer's Disease Neuroimaging Initiative. The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research. Alzheimers Dement. 2024 Oct; 20(10):7232-7247.

Young SR, Dworak EM, Kaat AJ, Adam H, Novack MA, Slotkin J, Stoeger J, Nowinski CJ, Hosseinian Z, Amagai S, Pila S, Diaz MV, Correa AA, Alperin K, Omberg L, Kellen M, Camacho MR, Landavazo B, Nosheny RL, Weiner MW, Gershon RM. Development and Validation of a Vocabulary Measure in the Mobile Toolbox. Arch Clin Neuropsychol. 2024 Aug 24; 39(6):714-723.

Okonkwo OC, Rivera Mindt M, Ashford MT, Conti C, Strong J, Raman R, Donohue MC, Nosheny RL, Flenniken D, Miller MJ, Diaz A, Soto AM, Ances BM, Beigi MR, Doraiswamy PM, Duara R, Farlow MR, Grossman HT, Mintzer JE, Reist C, Rogalski EJ, Sabbagh MN, Salloway S, Schneider LS, Shah RC, Petersen RC, Aisen PS, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative. A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce. JAMA Netw Open. 2024 Aug 01; 7(8):e2427073.

Guan DX, Mudalige D, Munro CE, Nosheny R, Smith EE, Ismail Z. The effect of study partner characteristics on the reporting of neuropsychiatric symptoms across the neurocognitive spectrum. Int Psychogeriatr. 2024 Aug; 36(8):675-688.

Novack MA, Young SR, Dworak EM, Kaat AJ, Slotkin J, Nowinski C, Yao L, Adam H, Stoeger J, Hosseinian Z, Amagai S, Pila S, Varela Diaz M, Almonte Correa A, Alperin K, Carlson S, Kellen M, Omberg L, Camacho MR, Landavazo B, Nosheny RL, Weiner MW, Gershon RC. Mobile toolbox (MTB) remote measures of executive function and processing speed: development and validation. J Int Neuropsychol Soc. 2024 Aug; 30(7):680-688.

Young SR, Dworak EM, Novack MA, Kaat AJ, Adam H, Nowinski CJ, Hosseinian Z, Slotkin J, Stoeger J, Amagai S, Varela Diaz M, Almonte Correa A, Alperin K, Omberg L, Kellen M, Camacho MR, Landavazo B, Nosheny RL, Weiner MW, Gershon R. Development and validation of an episodic memory measure in the Mobile Toolbox (MTB): Arranging Pictures. J Clin Exp Neuropsychol. 2024 05; 46(4):364-373.

Jaén C, Maute C, Mackin S, Camacho MR, Truran D, Nosheny R, Weiner MW, Dalton P. Remote olfactory assessment using the NIH Toolbox Odor Identification test and the brain health registry. PLoS One. 2024; 19(4):e0301264.

Ashford MT, Jin C, Neuhaus J, Diaz A, Aaronson A, Tank R, Eichenbaum J, Camacho MR, Fockler J, Ulbricht A, Flenniken D, Truran D, Mackin RS, Weiner MW, Mindt MR, Nosheny RL. Participant completion of longitudinal assessments in an online cognitive aging registry: The role of medical conditions. Alzheimers Dement (N Y). 2024 Jan; 10(1):e12438.

LaForte E, Young SR, Dworak EM, Novack MA, Kaat AJ, Adam H, Nowinski CJ, Hosseinian Z, Slotkin J, Amagai S, Diaz MV, Correa AA, Alperin K, Camacho M, Landavazo B, Nosheny R, Weiner MW, Gershon RM. Development and Validation the Mobile Toolbox (MTB) Spelling Test. J Prev Alzheimers Dis. 2024; 11(6):1673-1681.

Tank R, Diaz A, Ashford MT, Miller MJ, Eichenbaum J, Aaronson A, Landavazo B, Neuhaus J, Weiner MW, Mackin RS, Barnes J, Nosheny RL. Examining Demographic Factors, Psychosocial Wellbeing and Cardiovascular Health in Subjective Cognitive Decline in the Brain Health Registry Cohort. J Prev Alzheimers Dis. 2024; 11(3):787-797.

Manjavong M, Kang JM, Diaz A, Ashford MT, Eichenbaum J, Aaronson A, Miller MJ, Mackin S, Tank R, Weiner M, Nosheny R. Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer's Disease-Modifying Therapy. J Prev Alzheimers Dis. 2024; 11(5):1198-1205.

Manjavong M, Diaz A, Ashford MT, Aaronson A, Miller MJ, Kang JM, Mackin S, Tank R, Landavazo B, Truran D, Farias ST, Weiner M, Nosheny R. Performance of a Short Version of the Everyday Cognition Scale (ECog-12) to Detect Cognitive Impairment. J Prev Alzheimers Dis. 2024; 11(6):1741-1750.

Ashford MT, Aaronson A, Kwang W, Eichenbaum J, Gummadi S, Jin C, Cashdollar N, Thorp E, Wragg E, Zavitz KH, Cormack F, Banh T, Neuhaus JM, Ulbricht A, Camacho MR, Fockler J, Flenniken D, Truran D, Mackin RS, Weiner MW, Nosheny RL. Unsupervised Online Paired Associates Learning Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB®) in the Brain Health Registry. J Prev Alzheimers Dis. 2024; 11(2):514-524.

Nutley S, Nguyen BK, Mackin RS, Insel PS, Tosun D, Butters M, Aisen P, Raman R, Saykin AJ, Toga AW, Jack C, Weiner MW, Nelson C, Kassel M, Kryza-Lacombe M, Eichenbaum J, Nosheny RL, Mathews CA. Relationship of Hoarding and Depression Symptoms in Older Adults. Am J Geriatr Psychiatry. 2024 04; 32(4):497-508.

Aaronson A, Ashford MT, Jin C, Bride J, Decker J, DeNicola A, Turner RW, Conti C, Tank R, Truran D, Camacho MR, Fockler J, Flenniken D, Ulbricht A, Grill JD, Rabinovici G, Carrillo MC, Mackin RS, Weiner MW, Nosheny RL. Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection. Alzheimers Dement. 2024 02; 20(2):846-857.

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimers Dement. 2024 01; 20(1):652-694.

Nosheny RL, Yen D, Howell T, Camacho M, Moulder K, Gummadi S, Bui C, Kannan S, Ashford MT, Knight K, Mayo C, McMillan M, Petersen RC, Stricker NH, Roberson ED, Chambless C, Gersteneker A, Martin R, Kennedy R, Zhang Y, Kukull W, Flenniken D, Fockler J, Truran D, Mackin RS, Weiner MW, Morris JC, Li Y. Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening. JAMA Netw Open. 2023 09 05; 6(9):e2333786.

Langbaum JB, Maloney E, Hennessy M, Harkins K, Karlawish J, Nosheny RL, Bleakley A. How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults. Alzheimers Dement. 2023 12; 19(12):5399-5406.

Weiner MW, Aaronson A, Eichenbaum J, Kwang W, Ashford MT, Gummadi S, Santhakumar J, Camacho MR, Flenniken D, Fockler J, Truran-Sacrey D, Ulbricht A, Mackin RS, Nosheny RL. Brain health registry updates: An online longitudinal neuroscience platform. Alzheimers Dement. 2023 11; 19(11):4935-4951.

Ashford MT, Eichenbaum J, Jin C, Neuhaus J, Aaronson A, Ulbricht A, Camacho MR, Fockler J, Flenniken D, Truran D, Mackin RS, Maruff P, Weiner MW, Nosheny RL. Associations between Participant Characteristics and Participant Feedback about an Unsupervised Online Cognitive Assessment in a Research Registry. J Prev Alzheimers Dis. 2023; 10(3):607-614.

Mindt MR, Ashford MT, Zhu D, Cham H, Aaronson A, Conti C, Deng X, Alaniz R, Sorce J, Cypress C, Griffin P, Flenniken D, Camacho M, Fockler J, Truran D, Mackin RS, Hill C, Weiner MW, Byrd D, Turner Ii RW, Nosheny RL. The Community Engaged Digital Alzheimer's Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry. J Prev Alzheimers Dis. 2023; 10(4):847-856.

Ashford MT, Zhu D, Bride J, McLean E, Aaronson A, Conti C, Cypress C, Griffin P, Ross R, Duncan T, Deng X, Ulbricht A, Fockler J, Camacho MR, Flenniken D, Truran D, Mackin SR, Hill C, Weiner MW, Byrd D, Turner Ii RW, Cham H, Rivera Mindt M, Nosheny RL. Understanding Online Registry Facilitators and Barriers Experienced by Black Brain Health Registry Participants: The Community Engaged Digital Alzheimer's Research (CEDAR) Study. J Prev Alzheimers Dis. 2023; 10(3):551-561.

Mackin RS, Jin C, Burns E, Kassel M, Rhodes E, Nosheny R, Ashford M, Banh T, Eichenbaum J, Knight K, Tank R, Camacho MR, Fockler J, Truran D, Neuhaus J, Weiner M. Association of Major Depressive Disorder with remotely administered measures of cognition and subjective report of cognitive difficulties across the adult age spectrum. J Affect Disord. 2023 04 01; 326:198-205.

Mindt MR, Okonkwo O, Weiner MW, Veitch DP, Aisen P, Ashford M, Coker G, Donohue MC, Langa KM, Miller G, Petersen R, Raman R, Nosheny R. Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations. Alzheimers Dement. 2023 04; 19(4):1549-1557.

Nutley SK, Read M, Martinez S, Eichenbaum J, Nosheny RL, Weiner M, Mackin RS, Mathews CA. Hoarding symptoms are associated with higher rates of disability than other medical and psychiatric disorders across multiple domains of functioning. BMC Psychiatry. 2022 10 15; 22(1):647.

Weiner MW, Veitch DP, Miller MJ, Aisen PS, Albala B, Beckett LA, Green RC, Harvey D, Jack CR, Jagust W, Landau SM, Morris JC, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4. Alzheimers Dement. 2023 01; 19(1):307-317.

Ashford MT, Camacho MR, Jin C, Eichenbaum J, Ulbricht A, Alaniz R, Van De Mortel L, Sorce J, Aaronson A, Parmar S, Flenniken D, Fockler J, Truran D, Mackin RS, Rivera Mindt M, Morlett-Paredes A, González HM, Mayeda ER, Weiner MW, Nosheny RL. Digital culturally tailored marketing for enrolling Latino participants in a web-based registry: Baseline metrics from the Brain Health Registry. Alzheimers Dement. 2023 05; 19(5):1714-1728.

Nosheny RL, Amariglio R, Sikkes SAM, Van Hulle C, Bicalho MAC, Dowling NM, Brucki SMD, Ismail Z, Kasuga K, Kuhn E, Numbers K, Aaronson A, Moretti DV, Pereiro AX, Sánchez-Benavides G, Sellek Rodríguez AF, Urwyler P, Zawaly K, Dyadic Patterns of Subjective Report working group within the Subjective Cognitive Decline Professio. The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimers Dement (N Y). 2022; 8(1):e12357.

Sordo Vieira L, Guastello A, Nguyen B, Nutley SK, Ordway A, Simpson H, Zakrzewski J, Archer C, Liu N, Jean Gilles ME, Nosheny R, Weiner M, Mackin RS, Mathews CA. Identifying psychiatric and neurological comorbidities associated with hoarding disorder through network analysis. J Psychiatr Res. 2022 12; 156:16-24.

Sylvia LG, Lunn MR, Obedin-Maliver J, McBurney RN, Nowell WB, Nosheny RL, Mularski RA, Long MD, Merkel PA, Pletcher MJ, Tovey RE, Scalchunes C, Sutphen R, Martin AS, Horn EJ, O'Boyle M, Pitch L, Seid M, Redline S, Greenebaum S, George N, French NJ, Faria CM, Puvanich N, Rabideau DJ, Selvaggi CA, Yu C, Faraone SV, Venkatachalam S, McCall D, Terry SF, Deckersbach T, Nierenberg AA. Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial. J Med Internet Res. 2022 09 12; 24(9):e35620.

Largent EA, Walter S, Childs N, Dacks PA, Dodge S, Florian H, Jackson J, Llibre Guerra JJ, Iturriaga E, Miller DS, Moreno M, Nosheny RL, Obisesan TO, Portacolone E, Siddiqi B, Silverberg N, Warren RC, Welsh-Bohmer KA, Edelmayer RM, Participant FIRST Work Group. Putting participants and study partners FIRST when clinical trials end early. Alzheimers Dement. 2022 12; 18(12):2736-2746.

Howell T, Gummadi S, Bui C, Santhakumar J, Knight K, Roberson ED, Marson D, Chambless C, Gersteneker A, Martin R, Kennedy R, Zhang Y, Morris JC, Moulder KL, Mayo C, Carroll M, Li Y, Petersen RC, Stricker NH, Nosheny RL, Mackin S, Weiner MW. Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short Form. Alzheimers Dement (Amst). 2022; 14(1):e12331.

Sordo Vieira L, Nguyen B, Nutley SK, Bertolace L, Ordway A, Simpson H, Zakrzewski J, Jean Gilles ME, Nosheny R, Weiner M, Mackin RS, Mathews CA. Self-reporting of psychiatric illness in an online patient registry is a good indicator of the existence of psychiatric illness. J Psychiatr Res. 2022 07; 151:34-41.

Boccardi M, Handels R, Gold M, Grazia A, Lutz MW, Martin M, Nosheny R, Robillard JM, Weidner W, Alexandersson J, Thyrian JR, Winblad B, Barbarino P, Khachaturian AS, Teipel S. Clinical research in dementia: A perspective on implementing innovation. Alzheimers Dement. 2022 11; 18(11):2352-2367.

Nutley SK, Read M, Eichenbaum J, Nosheny RL, Weiner M, Mackin RS, Mathews CA. Health-related quality of life in hoarding: A comparison to chronic conditions with high disease burden. J Psychiatr Res. 2022 05; 149:68-75.

Fockler J, Ashford MT, Eichenbaum J, Howell T, Ekanem A, Flenniken D, Happ A, Truran D, Mackin RS, Blennow K, Halperin E, Coppola G, Weiner MW, Nosheny RL. Remote blood collection from older adults in the Brain Health Registry for plasma biomarker and genetic analysis. Alzheimers Dement. 2022 12; 18(12):2627-2636.

Ashford MT, Raman R, Miller G, Donohue MC, Okonkwo OC, Mindt MR, Nosheny RL, Coker GA, Petersen RC, Aisen PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2022 12; 18(12):2603-2613.

Kassam F, Chen H, Nosheny RL, McGirr A, Williams T, Ng N, Camacho M, Mackin RS, Weiner MW, Ismail Z. Cognitive profile of people with mild behavioral impairment in Brain Health Registry participants. Int Psychogeriatr. 2023 11; 35(11):643-652.

Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT, members of AGREEDementia. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All. J Alzheimers Dis. 2022; 90(3):953-962.

Banh T, Jin C, Neuhaus J, Mackin RS, Maruff P, Stricker N, Weiner MW, Nosheny RL. Unsupervised Performance of the CogState Brief Battery in the Brain Health Registry: Implications for Detecting Cognitive Decline. J Prev Alzheimers Dis. 2022; 9(2):262-268.

Howell T, Neuhaus J, Glymour MM, Weiner MW, Nosheny RL. Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale. J Prev Alzheimers Dis. 2022; 9(2):269-276.

Iaccarino L, La Joie R, Koeppe R, Siegel BA, Hillner BE, Gatsonis C, Whitmer RA, Carrillo MC, Apgar C, Camacho MR, Nosheny R, Rabinovici GD, Alzheimer's Disease Neuroimaging Initiative. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data. Neuroimage. 2022 02 01; 246:118775.

Nutley SK, Read M, Eichenbaum J, Nosheny RL, Weiner MW, Mackin RS, Mathews CA. Poor Sleep Quality and Daytime Fatigue Are Associated With Subjective but Not Objective Cognitive Functioning in Clinically Relevant Hoarding. Biol Psychiatry Glob Open Sci. 2022 Oct; 2(4):480-488.

Mackin RS, Rhodes E, Insel PS, Nosheny R, Finley S, Ashford M, Camacho MR, Truran D, Mosca K, Seabrook G, Morrison R, Narayan VA, Weiner M. Reliability and Validity of a Home-Based Self-Administered Computerized Test of Learning and Memory Using Speech Recognition. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2022 09; 29(5):867-881.

Albright J, Ashford MT, Jin C, Neuhaus J, Rabinovici GD, Truran D, Maruff P, Mackin RS, Nosheny RL, Weiner MW. Machine learning approaches to predicting amyloid status using data from an online research and recruitment registry: The Brain Health Registry. Alzheimers Dement (Amst). 2021; 13(1):e12207.

Fockler J, Kwang W, Ashford MT, Flenniken D, Hwang J, Truran D, Mackin RS, Jin C, O'Hara R, Hallmayer JF, Yesavage JA, Weiner MW, Nosheny RL. Brain health registry GenePool study: A novel approach to online genetics research. Alzheimers Dement (N Y). 2021; 7(1):e12118.

Ashford MT, Veitch DP, Neuhaus J, Nosheny RL, Tosun D, Weiner MW. The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status. Alzheimers Dement. 2021 05; 17(5):866-887.

Nutley SK, Camacho MR, Eichenbaum J, Nosheny RL, Weiner M, Delucchi KL, Mackin RS, Mathews CA. Hoarding disorder is associated with self-reported cardiovascular / metabolic dysfunction, chronic pain, and sleep apnea. J Psychiatr Res. 2021 02; 134:15-21.

Li Y, Xiong C, Aschenbrenner AJ, Chang CH, Weiner MW, Nosheny RL, Mungas D, Bateman RJ, Hassenstab J, Moulder KL, Morris JC. Item response theory analysis of the Clinical Dementia Rating. Alzheimers Dement. 2021 03; 17(3):534-542.

Nutley SK, Bertolace L, Vieira LS, Nguyen B, Ordway A, Simpson H, Zakrzewski J, Camacho MR, Eichenbaum J, Nosheny R, Weiner M, Mackin RS, Mathews CA. Internet-based hoarding assessment: The reliability and predictive validity of the internet-based Hoarding Rating Scale, Self-Report. Psychiatry Res. 2020 12; 294:113505.

Ashford MT, Neuhaus J, Jin C, Camacho MR, Fockler J, Truran D, Mackin RS, Rabinovici GD, Weiner MW, Nosheny RL. Predicting amyloid status using self-report information from an online research and recruitment registry: The Brain Health Registry. Alzheimers Dement (Amst). 2020; 12(1):e12102.

Nosheny RL, Camacho MR, Jin C, Neuhaus J, Truran D, Flenniken D, Ashford M, Carrillo MC, Fargo KN, Hendrix J, Hanna L, Rabinovici G, Maruff P, Mackin RS, Weiner MW. Validation of online functional measures in cognitively impaired older adults. Alzheimers Dement. 2020 10; 16(10):1426-1437.

Alosco ML, Tripodis Y, Baucom ZH, Mez J, Stein TD, Martin B, Haller O, Conneely S, McClean M, Nosheny R, Mackin S, McKee AC, Weiner MW, Stern RA. Late contributions of repetitive head impacts and TBI to depression symptoms and cognition. Neurology. 2020 08 18; 95(7):e793-e804.

Ashford MT, Eichenbaum J, Williams T, Camacho MR, Fockler J, Ulbricht A, Flenniken D, Truran D, Mackin RS, Weiner MW, Nosheny RL. Effects of sex, race, ethnicity, and education on online aging research participation. Alzheimers Dement (N Y). 2020; 6(1):e12028.

Nosheny RL, Jin C, Neuhaus J, Insel PS, Mackin RS, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative investigators. Study partner-reported decline identifies cognitive decline and dementia risk. Ann Clin Transl Neurol. 2019 12; 6(12):2448-2459.

Nosheny RL, Insel PS, Mattsson N, Tosun D, Buckley S, Truran D, Schuff N, Aisen PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults. Neurobiol Aging. 2019 10; 82:110-119.

Cholerton B, Weiner MW, Nosheny RL, Poston KL, Mackin RS, Tian L, Ashford JW, Montine TJ. Cognitive Performance in Parkinson's Disease in the Brain Health Registry. J Alzheimers Dis. 2019; 68(3):1029-1038.

Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, Finley S, Ulbricht A, Maruff P, Yaffe K, Mackin RS, Weiner MW. Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimers Dement (N Y). 2018; 4:565-574.

Mohlenhoff BS, Insel PS, Mackin RS, Neylan TC, Flenniken D, Nosheny R, Richards A, Maruff P, Weiner MW. Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults. J Clin Sleep Med. 2018 09 15; 14(9):1587-1594.

Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R, Ulbright A, Comacho M, Bickford D, Harel B, Maruff P, Weiner MW. Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry. Alzheimers Dement (Amst). 2018; 10:573-582.

Weiner MW, Nosheny R, Camacho M, Truran-Sacrey D, Mackin RS, Flenniken D, Ulbricht A, Insel P, Finley S, Fockler J, Veitch D. The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018 08; 14(8):1063-1076.

Insel PS, Palmqvist S, Mackin RS, Nosheny RL, Hansson O, Weiner MW, Mattsson N. Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information. Alzheimers Dement (Amst). 2016; 4:76-84.

Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology. Neurology. 2016 05 17; 86(20):1887-96.

Belichenko PV, Madani R, Rey-Bellet L, Pihlgren M, Becker A, Plassard A, Vuillermot S, Giriens V, Nosheny RL, Kleschevnikov AM, Valletta JS, Bengtsson SK, Linke GR, Maloney MT, Hickman DT, Reis P, Granet A, Mlaki D, Lopez-Deber MP, Do L, Singhal N, Masliah E, Pearn ML, Pfeifer A, Muhs A, Mobley WC. An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. PLoS One. 2016; 11(3):e0152471.

Aisen P, Touchon J, Andrieu S, Boada M, Doody R, Nosheny RL, Langbaum JB, Schneider L, Hendrix S, Wilcock G, Molinuevo JL, Ritchie C, Ousset PJ, Cummings J, Sperling R, DeKosky ST, Lovestone S, Hampel H, Petersen R, Legrand V, Egan M, Randolph C, Salloway S, Weiner M, Vellas B. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016; 3(2):68-74.

Jack CR, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, Gunter J, Gutman BA, Holland D, Hua X, Insel P, Kantarci K, Killiany RJ, Krueger G, Leung KK, Mackin S, Maillard P, Malone IB, Mattsson N, McEvoy L, Modat M, Mueller S, Nosheny R, Ourselin S, Schuff N, Senjem ML, Simonson A, Thompson PM, Rettmann D, Vemuri P, Walhovd K, Zhao Y, Zuk S, Weiner M. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimers Dement. 2015 Jul; 11(7):740-56.

Insel PS, Mattsson N, Mackin RS, Kornak J, Nosheny R, Tosun-Turgut D, Donohue MC, Aisen PS, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Ann Clin Transl Neurol. 2015 May; 2(5):534-47.

Nosheny RL, Belichenko PV, Busse BL, Weissmiller AM, Dang V, Das D, Fahimi A, Salehi A, Smith SJ, Mobley WC. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiol Dis. 2015 May; 77:173-90.

Nosheny RL, Insel PS, Truran D, Schuff N, Jack CR, Aisen PS, Shaw LM, Trojanowski JQ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. 2015 Jan; 36(1):273-82.

Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, Jack CR, Donohue MC, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative. Emerging β-amyloid pathology and accelerated cortical atrophy. JAMA Neurol. 2014 Jun; 71(6):725-34.

Mattsson N, Insel P, Nosheny R, Trojanowski JQ, Shaw LM, Jack CR, Tosun D, Weiner M, Alzheimer's Disease Neuroimaging Initiative. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiol Aging. 2014 Mar; 35(3):614-22.

Mattsson N, Insel P, Nosheny R, Zetterberg H, Trojanowski JQ, Shaw LM, Tosun D, Weiner M, Alzheimer's Disease Neuroimaging Initiative. CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders. Transl Psychiatry. 2013 Aug 20; 3:e293.

Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biol Psychiatry. 2014 Feb 01; 75(3):179-88.

Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis. 2012 Feb; 45(2):683-91.

Bachis A, Cruz MI, Nosheny RL, Mocchetti I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci Lett. 2008 Sep 12; 442(2):104-8.

Mocchetti I, Nosheny RL, Tanda G, Ren K, Meyer EM. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system. Ann N Y Acad Sci. 2007 Dec; 1122:144-54.

Mocchetti I, Bachis A, Nosheny RL, Tanda G. Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons. Neurotox Res. 2007 Sep; 12(2):135-43.

Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur J Neurosci. 2007 Apr; 25(8):2275-84.

Nosheny RL, Bachis A, Aden SA, De Bernardi MA, Mocchetti I. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J Neurobiol. 2006 Oct; 66(12):1311-21.

Bachis A, Aden SA, Nosheny RL, Andrews PM, Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis. J Neurosci. 2006 Jun 21; 26(25):6771-80.

Nosheny RL, Mocchetti I, Bachis A. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox Res. 2005 Oct; 8(1-2):187-98.

Nosheny RL, Bachis A, Acquas E, Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur J Neurosci. 2004 Dec; 20(11):2857-64.

Acquas E, Bachis A, Nosheny RL, Cernak I, Mocchetti I. Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotox Res. 2004; 5(8):605-15.

Belles C, Kuhl A, Nosheny R, Carding SR. Plasma membrane expression of heat shock protein 60 in vivo in response to infection. Infect Immun. 1999 Aug; 67(8):4191-200.